Juli Miller | Director of IR |
James Noble | CEO & Director |
Rafael Amado | Chief Medical Officer |
Robyn Karnauskas | Citi |
Peter Lawson | SunTrust Robinson Humphrey |
Ren Benjamin | Raymond James. |
Jonathan Chang | Leerink Partners |
Marc Frahm | Cowen and Company |
Soumit Roy | JonesTrading. |
Nicholas Abbott | Wells Fargo Securities |
Jenny Leeds | Bank of America Merrill Lynch |
Good day, ladies and gentlemen, and welcome to the Q2 2018 Adaptimmune Earnings Conference Call. [Operator Instructions] As a reminder, this call is being recorded. I will now turn the call over to Juli Miller.
You may begin.
Good morning, and welcome to Adaptimmune's conference call to discuss our second quarter 2018 financial results and other business updates.